ESARI
Live / Registered — Registered (as of 17 Jan 2023)
What this means for you
Registered since 17 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90819626
- Registration number
- 6952572
- Mark type
- Stylized text
- Filed
- 09 Jul 2021
- Published for opposition
- 01 Nov 2022
- Registered
- 17 Jan 2023
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis, ankylosing spondylarthritis, cancer, respiratory diseases, cardiovascular diseases, diabetes, blood disorders and diseases, multiple sclerosis, central nervous system disorders and diseases, and neurological, hematological, and lysosomal storage disorders; vaccines
Owner
- Sanofi Biotechnology, Paris, FR
- Sanofi Biotechnology, Paris, FR
- Sanofi Biotechnology, Paris, FR
Prosecution history
- 17 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 01 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Nov 2022 — PUBLISHED FOR OPPOSITION
- 12 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Sept 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Sept 2022 — EXAMINER'S AMENDMENT ENTERED
- 29 Sept 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Sept 2022 — EXAMINERS AMENDMENT E-MAILED
- 29 Sept 2022 — EXAMINERS AMENDMENT -WRITTEN
- 19 Sept 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Sept 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Sept 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Apr 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Apr 2022 — NON-FINAL ACTION E-MAILED